5th Floor, Rajapushpa Summit
Nanakramguda Rd, Financial District, Gachibowli
Hyderabad, Telangana - 500008
India
The Middle East & African pancreatic cancer market is expected to grow modestly from USD 87 million in 2015, growing at a CAGR of 10-17%.
Globally, pancreatic cancer is the 12th most common cancer in men and 11th most common cancer in women. Addiction to cigarettes and health history are considered to be the foremost reasons increasing the risk.
Middle East & Africa Pancreatic Cancer Therapeutics & Diagnostics Market-Market Dynamics
The report details several factors driving and restraining the market, some of which are listed below.
Drivers
Some factors contributing to the growth of the market are:
Restraints
Some factors limiting the growth of the market are:
The Middle East & African pancreatic cancer therapeutics & diagnostic market is segmented based on the type of cancer into endocrine and exocrine cancers. By the type of treatment, the market is segmented into surgery, chemotherapy, radiation therapy and targeted therapy. By the major tests, the market has been segmented into biopsy, endoscopic ultrasound, laparoscopy and CT scan ERCP. On the basis of geography, the market has been segmented into Qatar, Saudi Arabia, and South Africa.
Some of the key players in the market are:
What the Report Offers
5th Floor, Rajapushpa Summit
Nanakramguda Rd, Financial District, Gachibowli
Hyderabad, Telangana - 500008
India
+1 617-765-2493
We are always looking to hire talented individuals with equal and extraordinary proportions of industry expertise, problem solving ability and inclination.
Interested? Please email us
[email protected]© 2020. All Rights Reserved to Mordor Intelligence.